Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?
Publication
, Journal Article
Young, KH
Published in: Cancer Commun (Lond)
March 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cancer Commun (Lond)
DOI
EISSN
2523-3548
Publication Date
March 2021
Volume
41
Issue
3
Start / End Page
273 / 274
Location
United States
Related Subject Headings
- T-Lymphocytes
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Humans
- Hematopoietic Stem Cell Transplantation
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Young, K. H. (2021). Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond), 41(3), 273–274. https://doi.org/10.1002/cac2.12148
Young, Ken H. “Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?” Cancer Commun (Lond) 41, no. 3 (March 2021): 273–74. https://doi.org/10.1002/cac2.12148.
Young KH. Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond). 2021 Mar;41(3):273–4.
Young, Ken H. “Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?” Cancer Commun (Lond), vol. 41, no. 3, Mar. 2021, pp. 273–74. Pubmed, doi:10.1002/cac2.12148.
Young KH. Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond). 2021 Mar;41(3):273–274.
Published In
Cancer Commun (Lond)
DOI
EISSN
2523-3548
Publication Date
March 2021
Volume
41
Issue
3
Start / End Page
273 / 274
Location
United States
Related Subject Headings
- T-Lymphocytes
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Humans
- Hematopoietic Stem Cell Transplantation
- 3211 Oncology and carcinogenesis